XBiotech director John Simard buys 70,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
XBiotech Inc. (XBIT) director and 10% owner John Simard purchased 70,000 shares of common stock at $2.0487 per share on November 3, 2026. He held 4,261,690 shares directly after the purchase. No Rule 10b5-1 plan was reported for the purchase.
Insider Trade Summary
Net Buyer: 70,000 shares
Net Buy
1 txn
Insider
SIMARD JOHN
Role
Director, 10% Owner
Bought
70,000 shs ($143K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 70,000 | $2.0487 | $143K |
Holdings After Transaction:
Common Stock — 4,261,690 shares (Direct)
Key Figures
Shares purchased: 70,000 shares
Purchase price: $2.0487 per share
Direct shares held after purchase: 4,261,690 shares
3 metrics
Shares purchased
70,000 shares
John Simard's direct purchase on November 3, 2026
Purchase price
$2.0487 per share
John Simard's purchase on November 3, 2026
Direct shares held after purchase
4,261,690 shares
John Simard's resulting direct position
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.